TCTAP A-104 Clinical Outcomes of Amphilimus Drug Eluting Stents in an All-comers Southeast Asian Registry

Amphilimus-eluting stent (AES) is a novel polymer-free drug-eluting stent (DES) that combines sirolimus with fatty acid as anti-proliferative drug and has shown promising results in the percutaneous coronary intervention (PCI). There is limited data on the safety and efficacy of AES in Asian